Diaceutics offers a comprehensive suite of technologies aimed at enhancing the launch and commercialization of precision medicine diagnostics. Central to their approach is DXRX - The Diagnostic Network®, which serves as a pioneering platform that connects various stakeholders in the precision medicine ecosystem, including pharmaceutical companies, clinical testing labs, and healthcare professionals. This network facilitates collaboration and provides access to real-world diagnostic testing data, enabling timely and informed decision-making. Additionally, Diaceutics leverages its expertise in precision medicine to create tailored educational content that engages physicians, thereby driving awareness and increasing testing rates for novel therapies and biomarkers.

The company also emphasizes the importance of actionable insights and strategic engagement through its Tech Enabled Services. These services include the construction of virtual advisory boards that bring together key opinion leaders and stakeholders to discuss and evaluate the utility of biomarker testing and reimbursement pathways. By promoting education and awareness among labs and clinicians, Diaceutics aims to optimize the commercialization process for new diagnostics and therapies. Their initiatives are designed to bridge the gap between pharmaceutical companies and the lab community, ensuring that new tests are effectively implemented and that high-quality standards are maintained throughout the testing process.

Ireland

At Diaceutics we believe that every patient should have access to the right treatment at the right time. We provide the world’s leading pharmaceutical companies with an end-to-end solution for the launch of precision medicine diagnostics enabled by DXRX – The Diagnostic Network®.  

DXRX is the world’s first diagnostic commercialization platform for precision medicine, integrating multiple pipelines of real-world diagnostic testing data from a global network of laboratories. 

Diaceutics

Company Details